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degree of IPPA RO was significantly greater than forTI (p < 0.01). In addition,
IPPA OM significantly improved from 0.62 ± 0.05 initially to 0.71 ± 0.05 after
only20 min of RO (p < 0.01) and further improved to 0.85 ± 0.05 after 120 min
indicating susbstantial rest RO. Thus, in this canine model of sustained low
flow and systolic dysfunction, IPPA RO is superior to TI for the assessment
of myocardial viability.
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1789-31 Does 99mTc·Sestamibi Gated·SPECT Provide
Additional Information Over Ungated-Sestamibi and
201·TI Reinjection Imaging in Viability Assessment?
Raffaele Giubbini, Elisa Milan, Orazio Zoccarato, Marco Metra, Federica Ettori,
Omelia Leonzi, Luigi Niccoli, Ami S. Iskandrian. Nuclear Medicine Dptand Chair of
Cardiology, Civic Hospital and University ofBrescia, Brescia, ltalv; Philadelphia Heart
Institute, Presbyterian Medical Center. Philadelphia, PA
Sestamibi imaging is commonly believed to underestimate viability, how-
ever its optimal imaging characteristics are not completely explored. Gated-
SPECT permits assessment of an original marker of viability, which is the ra-
dionuclide myocardial wall thickening (RMWT). defined as increase in count
density at end systole. Aims of this study were: 11 to compare 201-TI rein-
jection and ungated Sestamibi patterns to RMWT in territories with base-
line segmental LV dysfunction and 2) to compare the accuracy of these 3
markers to predict functional recovery after successful PTCA. We studied
18 pts with segmental LV asynergies by contrast angiography in myocardial
segments supplied by > 75% stenotic coronary arteries. All pts were stud-
ied by thallium stress-redistribution-reinjection SPECT and by rest Sestamibi
gated-SPECT. The assessment of LV performance was based on rest gated
radionuclide angiography (RNA) performed before and 2 months after PTCA.
The analysis of RMWT was done by visual evaluation in cine mode and by
semiquantitative circumferential profile analysis. A 20 segments model was
used for SPECT and a 9 segments for RNA. Pre and post PTCA global LV
EF increased from 47 ± 9% to 50 ± 10 (p < 0.05). The pts who failed to in-
crease the EF by more than 3% had significantly more asynergic segments
that failed to show RMWT compared to pts with EF improvement (3.9 ± 3.8
vs 0.4 ± 1.1, P < 0.05). 21/360 segments (6%1 showed a severe 201-TI de-
fect (>50% of the maximal uptake) after reinjection and 31 (9%) a severe
detect by ungated-Sestamibi. Persistent RMWT was present in 7/21 (33%)
and 14/31 (45%) segments respectively. In 61 of 162 segments (38%), there
were severe regional wall motion abnormalities. Of these, 28 segments im-
proved after PTCA and 33 did not. The sensitivities for functional improve-
ment after PTCA for gated-SPECT, reinjection 201-TI and ungated-Sestamibi
were 93, 86 and 64% respectively (gated vs ungated-Sestamibi, p < 0.05).
The corresponding specificities were 73, 45 and 61 %, respectively (gated-
Sestamibi vs 201-TI reinjection, p< 0.05). Thus, the persistence of RMWT,
as detected by gated-SPECr. in asynergic areas predicts functional improve-
ment after PTCA independent from the presence of severe defects by 201-TI
reinjection or ungated-Sestamibi studies.
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Simultaneous Dual Isotope Imaging with 99mTc_MIBI
and 18FDG-SPECT for Evaluation of Myocardial
Ischemia
Searle W. Videlefsky, William H. Martin, Dominique Delbeke, James A. Patton,
Michelle G. Campbell, Martin P. Sandler. Vanderbilt University, Nashville, Tennessee
An ultra high energy collimator for the Apex Helix (Elscint) was designed and
fabricated with acceptable specifications for imaging both 99mTc and 18F.
Five patients (59.4 ± 11.5 years, 4 males/l female) with a left ventricular
ejection fraction of <35% were studied to assess the ability of identifying
hibernating myocardium using dual isotope, single acquisition (SOIA) SPECT
with 99mTc_M IB 1/18 FOG. Patients were loaded with 25-50 grams of oral glu-
cose and after approximately 60 minutes injected with 25 mCi of 99mTc_
MIBI and 10 mCi of 18FOG. After a 35-minute distribution phase, they un-
derwent 18FOG-PET followed immediately by SOIA-SPECT (30 min acquisi-
tionl. There was excellent correlation between the 18FOG-PET/18FOG-SPECT
images. The study identified 2 patients with matched (MAl defects and 2
with mismatched (MM) (hibernating myocardium) defects. One patient had
both a MM and a MA defect. Eighteen different patients (56.7 ± 12.2 years,
11 males!7 females) were studied using a rest (10 mCi 18FOG)/stress (25
mCi 99mTc_MIBI) SOIA-SPECT protocol to identify both acute on chronic and
chronic myocardial ischemia. After oral glucose loading and myocardial dis-
tribution of 18FDG patients underwent exercise or pharmacological stress
followed by administration of 99mTc_MIBI. Patients were imaged 15-30 min-
utes later with SDIA-SPECT. In the patients studied there were 16 MA de-
fects, 12 MM defects and 2 normal studies. Eight of the 18 patients studied
underwent cardiac catheterization with no false positive results.
Conc/usion: Simultaneous dual isotope acquisition-SPECT using 18FDG/
99mTc_MIBI may provide an alternative, accurate, cost-effective method com-
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pared to 13NH3/18FDG or 201TI reinjection to identify both acute on chronic
myocardial ischemia and hibernating myocardium.
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Use of Rest Tomoscintigraphy with a Methylated
Labelled Free Fatty Acid to Detect Myocardial
Viability After Myocardial Infarction in Areas with
Irreversible Defects on Exercise Single-Photon
Emission-Computed Tomography-Tl201 with
Rest-Reinjection
Michael Angioi", Pierre-Yves Marie, Nicolas Danchin, Pierre Olivier, Gilles Karcher,
Yves Juilliere, Alain Bertrand, Fran,ois Cherrier. Services de Cardiologie et de
Medecine NuclBaire, CHU de Nancy, France
Detection of residual myocardial viability after myocardial infarction 1MI)
remains a diagnostic challenge. The aim of this study was to determine
whether uptake of [123-1]-16-lodo-3-Methylhexadecanoic acid (MIHA) inside
areas with irreversible defects on exercise SPECT-TI201 with rest-reinjection
was related to myocardial viability, as defined by subsequent improvement
in perfusion or contractility after percutaneous transluminal coronary angio-
plasty (PTCA).
In a prospective study, 62 patients (pts) with MI underwent exercise
SPECT-TI201 with rest-reinjection, rest-SPECT with MIHA, and X-ray quan-
titative left ventricular (LVI angiography, prior to a successful PTCA of the
MI-related artery. In pts without restenosis (n = 33). a 2:4 months follow-
up evaluation of LV contractility (X-ray LV angiography, n = 33) and exercise
perfusion (SPECT-TL201, n = 28) was obtained. For each MI territory, a 2-
segment (sgt) division was used for analysis of segmental wall-motion on
X-ray angiography, and of perfusion on SPECT-TL201 and for MIHA uptake.
Before PTCA, exercise defects reversibility was observed at T1201-
reinjection in 39/66 sgts, and was related to subsequent improvement in
contractility for 29 (p < 0.01; sens.: 73%, spec.: 62%). Among 23 sgts with
irreversible Tl201-reinjection defects, however an increased uptake was evi-
denced by MIHA in 11 sgts (48%). of which 9 had subsequent improvement
in contractility (p < 0.01; sens. 82%, spec.: 83%).
For patients who underwent repeat SPECT-TL201 (n = 28). exercise de-
fect reversibility was observed before PTCA in 32/56 sgts, of which 30 had
subsequent improvement in exercise perfusion (p < 0.001; sens.: 71 %,
spec.: 86%). Among 20 sgts with irreversible Tl201-reinjection defects, an
increased uptake was evidenced with MIHA in 8 sgts (40%) and all had sub-
sequent improvement in exercise perfusion (p = 0.01; sens.: 67%, spec.:
100%).
Thus after MI, residual viability can exist in areas with irreversible defects
on exercise SPECT-TL201 with rest reinjection. In these areas, MIHA uptake
correlates with residual viability, as evidenced by subsequent improvement
in both myocardial perfusion and function after successful PTCA.
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1789-61 Scintigraphic Assessment of Myocardial Viability in
the Late Phase (>4 weeks) of Myocardial Infarction:
Comparison Between Sestamibi and Thallium-201
Jean Maublant, Janusz Lipiecki, Bernard Citron, Daniele Mestas,
Jean-Michel Tarle!. Annie Veyre, Jean Ponsonnaille. University ofAuvergne,
Clermont-Ferrand, France
This study was part of an open multicenter protocol to evaluate the value of
tomographic myocardial perfusion imaging with sestamibi and thallium-201
ITI-2011 in the detection of ischemic but viable myocardium in chronic stable
coronary artery disease patients with left ventricular dysfunction. A series of
20 patients (pts) with >75% coronary artery stenosis and wall motion abnor-
mality, who were scheduled for percutaneous transluminal coronary angio-
plasty (PTCA) and had a >4-week old myocardial infarction were included.
All pts underwent (a) within 21 days before PTCA, a separate-day rest and
stress sestamibi study, a same-day stress, redistribution and 4-hour reinjec-
tion study with TI-201, and a gated blood pool study, (bl within 4-6 weeks
after PTCA, another sestamibi and gated blood pool studies. Perfusion and
wall motion abnormalities were graded visually. Among the 15 pts who com-
pleted the study, left ventricular ejection fraction showed improvement after
PTCA in 12 pts (39.9 ± 10.5 vs 45.3 ± 10.8, P < 0.001), while wall motion
improved in 18 segments repartited into 7 pts. Among these 18 viable areas,
pre-PTCA tracer uptake was normal or near-normal in 28% with sestamibi at
rest, and in 56% with TI-201 at redistribution. After exercise, reversible is-
chemia was observed in 44% of these segments with sestamibi and in 55%
with TI-201 .
In conclusion (a) residual myocardial viability was present in nearly 50% of
the pts with a <4-week old myocardial infarct, (bl in the viable areas, at rest,
sestamibi uptake was more often abnormal than TI-201 uptake.
